Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 19,751,284 | 19,751,284 | 0 | $1.07B | $771.68M | 31.45% | -$297.85M |
| Axsome Therapeutics, Inc.(AXSM) | 1,388,064 | 1,690,221 | +302,157 | $117.44M | $197.13M | 8.03% | +$79.69M |
| Revolution Medicines, Inc.(RVMD) | 4,181,179 | 4,982,384 | +801,205 | $182.88M | $176.18M | 7.18% | -$6.71M |
| Kymera Therapeutics, Inc.(KYMR) | 5,161,801 | 5,161,801 | 0 | $207.66M | $141.28M | 5.76% | -$66.38M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 2,796,513 | 2,796,513 | 0 | $115.64M | $125.98M | 5.13% | +$10.35M |
| Protagonist Therapeutics Inc | 1,900,015 | 2,575,015 | +675,000 | $73.34M | $124.53M | 5.08% | +$51.19M |
| GH Research PLC(GHRS) | 10,400,158 | 8,827,712 | -1,572,446 | $72.80M | $97.37M | 3.97% | +$24.57M |
| Xoma Royalty Corporation | 3,633,743 | 2,983,026 | -650,717 | $95.49M | $59.45M | 2.42% | -$36.04M |
| Ionis Pharmaceuticals, Inc.(IONS) | 0 | 1,913,385 | +1,913,385 | $0 | $57.73M | 2.35% | +$57.73M |
| Zymeworks Inc.(ZYME) | 4,308,935 | 4,308,935 | 0 | $63.08M | $51.32M | 2.09% | -$11.76M |
| Kura Oncology, Inc.(KURA) | 2,567,469 | 7,754,129 | +5,186,660 | $22.36M | $51.18M | 2.09% | +$28.81M |
| Cullinan Therapeutics, Inc.(CGEM) | 5,750,683 | 5,750,683 | 0 | $70.04M | $43.53M | 1.77% | -$26.51M |
| AC Immune SASHS(ACIU) | 19,522,436 | 19,822,436 | +300,000 | $52.71M | $37.07M | 1.51% | -$15.64M |
| Tyra Biosciences, Inc.(TYRA) | 3,944,194 | 3,944,194 | 0 | $54.82M | $36.68M | 1.50% | -$18.14M |
| Lakefront Biotherapeutics NVADR(LKFT) | 1,569,422 | 1,454,422 | -115,000 | $43.16M | $36.54M | 1.49% | -$6.62M |
| Celcuity Inc.(CELC) | 3,466,000 | 3,466,000 | 0 | $45.37M | $35.04M | 1.43% | -$10.33M |
| Verve Therapeutics Inc | 6,904,050 | 6,904,050 | 0 | $38.94M | $31.55M | 1.29% | -$7.39M |
| Structure Therapeutics IncADS | 1,771,417 | 1,771,417 | 0 | $48.04M | $30.66M | 1.25% | -$17.38M |
| Xencor, Inc.(XNCR) | 2,288,760 | 2,740,141 | +451,381 | $52.60M | $29.16M | 1.19% | -$23.44M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 2,764,471 | 5,660,132 | +2,895,661 | $19.19M | $26.26M | 1.07% | +$7.08M |
| Septerna, Inc.(SEPN) | 2,452,024 | 4,396,124 | +1,944,100 | $56.15M | $25.45M | 1.04% | -$30.70M |
| Eledon Pharmaceuticals, Inc.(ELDN) | 6,293,282 | 6,293,282 | 0 | $25.93M | $21.33M | 0.87% | -$4.59M |
| Cidara Therapeutics Inc | 1,092,796 | 924,642 | -168,154 | $29.37M | $19.92M | 0.81% | -$9.46M |
| Olema Pharmaceuticals, Inc.(OLMA) | 5,715,893 | 5,295,893 | -420,000 | $33.32M | $19.91M | 0.81% | -$13.41M |
| Palvella Therapeutics, Inc.(PVLA) | 696,555 | 696,555 | 0 | $8.36M | $19.50M | 0.79% | +$11.14M |
| Foghorn Therapeutics Inc.(FHTX) | 5,302,000 | 5,302,000 | 0 | $25.03M | $19.35M | 0.79% | -$5.67M |
| Iteos Therapeutics Inc | 2,325,000 | 3,075,000 | +750,000 | $17.86M | $18.36M | 0.75% | +$501.8K |
| 4d Molecular Therapeutics In | 2,670,642 | 4,561,289 | +1,890,647 | $14.88M | $14.73M | 0.60% | -$142.5K |
| Essa Pharma Inc | 8,748,629 | 8,748,629 | 0 | $15.66M | $13.82M | 0.56% | -$1.84M |
| Annexon, Inc.(ANNX) | 7,000,000 | 7,000,000 | 0 | $35.91M | $13.51M | 0.55% | -$22.40M |
| Verastem, Inc.(VSTM) | 2,100,468 | 2,100,468 | 0 | $10.86M | $12.67M | 0.52% | +$1.81M |
| Rapt Therapeutics Inc | 9,237,556 | 9,237,556 | 0 | $14.60M | $11.27M | 0.46% | -$3.33M |
| Repare Therapeutics Inc | 10,333,600 | 10,333,600 | 0 | $13.54M | $10.19M | 0.42% | -$3.35M |
| Immunic, Inc.(IMUX) | 8,902,972 | 8,902,972 | 0 | $8.90M | $9.70M | 0.40% | +$801.3K |
| Avalo Therapeutics, Inc.(AVTX) | 1,036,679 | 1,036,679 | 0 | $7.70M | $8.30M | 0.34% | +$601.3K |
| Third Harmonic Bio Inc | 2,372,933 | 2,372,933 | 0 | $24.42M | $8.23M | 0.34% | -$16.18M |
| Vigil Neuroscience Inc | 1,813,633 | 4,013,633 | +2,200,000 | $3.08M | $7.14M | 0.29% | +$4.06M |
| TScan Therapeutics, Inc.(TCRX) | 2,989,474 | 4,889,474 | +1,900,000 | $9.09M | $6.75M | 0.28% | -$2.34M |
| Molecular Partners AGADS(MOLN) | 1,353,968 | 1,353,968 | 0 | $6.46M | $5.51M | 0.22% | -$947.8K |
| Ikena Oncology Inc | 4,006,564 | 4,006,564 | 0 | $6.57M | $5.13M | 0.21% | -$1.44M |
| Forte Biosciences Inc | 594,282 | 594,282 | 0 | $13.50M | $4.61M | 0.19% | -$8.88M |
| Allakos Inc | 16,552,417 | 16,552,417 | 0 | $20.03M | $3.77M | 0.15% | -$16.26M |
| CytomX Therapeutics, Inc.(CTMX) | 5,228,461 | 5,228,461 | 0 | $5.39M | $3.32M | 0.14% | -$2.06M |
| Tenax Therapeutics, Inc.(TENX) | 339,549 | 339,549 | 0 | $2.10M | $2.22M | 0.09% | +$122.2K |
| Inventiva S.A.ADS(IVA) | 686,040 | 686,040 | 0 | $1.47M | $2.06M | 0.08% | +$583.1K |
| Glycomimetics Inc | 9,544,262 | 9,544,262 | 0 | $2.38M | $2.00M | 0.08% | -$372.2K |
| SAB Biotherapeutics, Inc.(SABS) | 917,826 | 917,826 | 0 | $3.51M | $1.24M | 0.05% | -$2.27M |
| Newamsterdam Pharma Company ORDINARY SHARES | 0 | 59,065 | +59,065 | $0 | $1.21M | 0.05% | +$1.21M |
| Ovid Therapeutics Inc.(OVID) | 3,853,818 | 3,853,818 | 0 | $3.60M | $1.20M | 0.05% | -$2.40M |
| Engene Holdings IncW EXP 10 31 202 *W EXP 10/31/202 | 945,402 | 945,402 | 0 | $803.7K | $605.1K | 0.02% | -$198.6K |
| Nls Pharmaceutics Ltd | 143,676 | 143,676 | 0 | $303.2K | $221.3K | 0.01% | -$81.9K |
| 89bio Inc | 4,333,885 | 0 | -4,333,885 | $33.89M | $0 | — | -$33.89M |
| Agios Pharmaceuticals, Inc.(AGIO) | 1,073,755 | 0 | -1,073,755 | $35.28M | $0 | — | -$35.28M |
| Elevation Oncology Inc | 2,966,836 | 0 | -2,966,836 | $1.67M | $0 | — | -$1.67M |
| Engene Holdings Inc COM | 2,106,037 | 0 | -2,106,037 | $14.01M | $0 | — | -$14.01M |